![Preetam Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Preetam Shah
Direttore Finanziario/CFO presso
ELICIO THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/07/2026
Profilo
Preetam Shah is the founder of Saisarva LLC, founded in 2010.
Dr. Shah is currently the Treasurer, Chief Financial & Strategy Officer at Elicio Therapeutics, Inc. since 2025.
Former positions include Director-Healthcare Investment Banking at Barclays Capital, Inc., Director-Healthcare Investment Banking at Lordes Capital Ltd., Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2019 to 2021, Vice President-Healthcare Investment Banking at Canaccord Genuity, Inc. from 2013 to 2016, Vice President-U.S.
Operations & Investments at Reliance Capital Usa Ventures LLC from 2006 to 2009, and Chief Financial & Accounting Officer at Cidara Therapeutics, Inc. from 2024 to 2025.
Education includes a doctorate from the University of Mississippi Medical Center, an MBA from The Wharton School of the University of Pennsylvania, and an undergraduate degree from McDaniel College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 16/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Posizioni attive di Preetam Shah
| Società | Posizione | Inizio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 24/03/2025 |
Precedenti posizioni note di Preetam Shah
| Società | Posizione | Fine |
|---|---|---|
| CIDARA THERAPEUTICS | Direttore Finanziario/CFO | 24/02/2025 |
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore Finanziario/CFO | 31/08/2021 |
Canaccord Genuity, Inc.
 Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2016 |
Saisarva LLC | Fondatore | 01/01/2013 |
Reliance Capital Usa Ventures LLC | Direttore degli Investimenti | 01/01/2009 |
Formazione di Preetam Shah
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
69
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McDaniel College
 McDaniel College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lordes Capital Ltd.
 Lordes Capital Ltd. Investment Banks/BrokersFinance Provides investment banking and advisory services | Finance |
University of Mississippi Medical Center
 University of Mississippi Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Reliance Capital Usa Ventures LLC | |
Saisarva LLC | |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
